These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 20237640

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cell-penetrating peptides in drug development: enabling intracellular targets.
    Chen L, Harrison SD.
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156
    [Abstract] [Full Text] [Related]

  • 24. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R, Fotin-Mleczek M, Hufnagel H, Brock R.
    Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
    [Abstract] [Full Text] [Related]

  • 25. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR, Gibbons J, Verma AK, Kanwar RK.
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.
    Sugita T, Yoshikawa T, Mukai Y, Yamanada N, Imai S, Nagano K, Yoshida Y, Shibata H, Yoshioka Y, Nakagawa S, Kamada H, Tsunoda S, Tsutsumi Y.
    Biochem Biophys Res Commun; 2007 Nov 30; 363(4):1027-32. PubMed ID: 17923117
    [Abstract] [Full Text] [Related]

  • 32. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells.
    Snyder EL, Dowdy SF.
    Curr Opin Mol Ther; 2001 Apr 30; 3(2):147-52. PubMed ID: 11338927
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Properties of cell penetrating peptides (CPPs).
    Kerkis A, Hayashi MA, Yamane T, Kerkis I.
    IUBMB Life; 2006 Jan 30; 58(1):7-13. PubMed ID: 16540427
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C, Nielsen HM.
    Expert Opin Drug Deliv; 2008 Jan 30; 5(1):105-17. PubMed ID: 18095931
    [Abstract] [Full Text] [Related]

  • 39. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S, Morris M, Heitz F, Divita G.
    Adv Drug Deliv Rev; 2008 Mar 01; 60(4-5):537-47. PubMed ID: 18037526
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.